ClinicalTrials.Veeva

Menu

Pleural Bleomycin vs Mechanical Abrasion in Malignant Pleural Effusion

A

Assiut University

Status

Begins enrollment this month

Conditions

Malignant Pleural Effusion

Treatments

Procedure: Group 2 chemical pleurodesis by bleomycin)
Procedure: Group 1 (mechanical pleurodesis)

Study type

Interventional

Funder types

Other

Identifiers

NCT06691009
Interventions for MPE

Details and patient eligibility

About

Comparision between pleurodesis by pleural abrasion using medical thoracoscopy and bleomycin instillation via indwelling pleural catheter. Evaluating the effectiveness of pleural abrasion using medical thoracoscopy in patients with malignant pleural effusion and evaluating the role of ROSE in diagnosis and management of malignant pleural effusion

Full description

Malignant pleural effusion cause significant morbidity so drainage effusion can provide great palliation and improve quality of life of these patients. There are several diagnostic tools for diagnosing malignant pleural effusion as pleural fluid cytology, closed pleural biopsy or thoracosopic pleural biopsy. Medical thoracoscopy has significant role in diagnosis and management of malignant pleural effusion. Also, pleurodesis may be performed through it by mechanical methods as pleural abrasion or chemical methods by talc poudrage, bleomycin or cisplatin instillation . and surgically through pleurectomy. Recently, using of ROSE (Rapis On-Site Examination) technique during medical thoracoscopy showed high accuracy for distinguishing between benign and malignant lesions, and this help in decision making. In our study, we will use mechanical pleurodesis by pleural abrasion using medical thoracoscpy and chemical pleurodesis by instillation of bleomycin via indwelling pleural catheter.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who are 18 years old or more.
  • patients with rapidly accumulating moderate & massive malignant pleural. effusion that need frequent aspiration to relieve dyspnea and affect quality of life of the patient.

Exclusion criteria

  • patients not fit for thoracoscoy.
  • patients with life expectency less than 1 month .
  • trapped lung (endobronchial lesion).
  • excessive pleural adhesios.
  • mild effusion not need frequent aspiration and not affect
  • quality of life .
  • patients with chest infection : pneumonia , empyema .
  • patients with performance status that doesn't expected to increase by 1

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

70 participants in 2 patient groups

Group 1 (Mechanical pleurodesis)
Experimental group
Description:
Pleural abrasions will be done by scrubbing the parietal and visceral pleura until a uniform aspect of bloody pleura by a piece of gauze attached to the end of a holding forceps, and intercostal tube will then placed and monitoring of lung expansion will be done through serial CXR and chest ultrasound follow up and when the lung is fully expanded the tube will be clamped for two hours and follow up CXR will be done for follow up and then the tube removed.
Treatment:
Procedure: Group 1 (mechanical pleurodesis)
Group 2 (Chemical pleurodesis by bleomycin)
Experimental group
Description:
Those Patients will have indwelling pleural catheter through which pleural fluid will be drained until dryness and then pleurodesis will be done by 60 mg bleomycin dissolved in 50 ml 0.9% saline and 10 ml 2% xylocaine solution then the catheter will be clamped for 6 hours.
Treatment:
Procedure: Group 2 chemical pleurodesis by bleomycin)

Trial contacts and locations

1

Loading...

Central trial contact

Montaser G Zahran, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems